Informed Consent to those offered Avian Influenza H5 vaccines
A further update on FOI responses from the MHRA
This is a brief note to inform readers that we are still awaiting the MHRA’s Internal review of their evasive answers to our requests to see the informed consent provided to licensed avian H5 influenza vaccine recipients.
You can read the MHRA holding answers here: The last one came in today, Tuesday.
The background to the request is here:
The H5 Avian Influenza Vaccines - Update on FOI responses from the MHRA
In several posts, we have reported our efforts to get to the bottom of the Avian Influenza threat and the UK’s purchase and stockpiling of relevant vaccines. Our quest started before Christmas, responding to the news that the UKHSA had purchased over 5 million doses of an Influenza H5 “pandemic” vaccine.
We are probing the licensing of the new H5 vaccines that use an existing predicate vaccine for approval. We are also still awaiting an answer to our request to see the bioequivalence studies on which the analogy is supposedly based.
As an aside, analogy logic is a form of induction. You compare A with B, assuming that the known characteristics of A, which it shares with B, also apply to the unknown characteristics.
In this case, the regulator is assuming that the vaccine Incellipan is similar to Aflumov, the predicate. Since Aflumov is licensed, the regulator has assumed that Incellipan should be licensed, too - which it is.
Although we won’t delve too d…
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.